HAEMOPHILIA TREATMENT CENTRE

Slides:



Advertisements
Similar presentations
Basic coagulation techniques and Quality control issues
Advertisements

INHIBITOR TO ANTIHEMOPHILIC FACTOR Djajadiman Gatot Division of Hematology Oncology Department of Child Health FMUI - CMGH.
TREATMENT Coagulopathy of Liver Failure. Fresh Frozen Plasma – Most effective way to correct hemostasis in patients with liver failure – Infusion (5-10mL/kg)
WFH Bangkok 2004 Factor VIII - Von Willebrand Factor Inhibitors and Immune Tolerance The Key Issue in Haemophilia A.
Non Imaging In Vivo Red Cell Survival. Test done to determine the rate of disappearance of labeled red blood cells from circulation.
Faculty of Allied Medical Science
Quantitative Fibrinogen Mr. Mohammed A. Jaber.  Fibrinogen assays are quantitative techniques to measure the amount of functional fibrinogen present.
Coagulation Time Tube Method Mr. Mohammed A. Jaber.
Week 6: Secondary Hemostasis Plasmatic factors Plasmatic factors Intrinsic pathway Intrinsic pathway Extrinsic pathway Extrinsic pathway Specimen Specimen.
MISHA MAZHAR 2k10-NUST-BS-V&I-54.  Mutations in F8 or F9 genes.  Leads to lack of proteins made by these genes.  F8 responsible for making the blood.
One Stage Factor V Assay
Tests to measure fibrin clot Lecture 9: General Approach in Investigation of Haemostasis.
MLAB Coagulation Keri Brophy-Martinez
General Approach of Haemostasis
MIXING STUDIES General Approach of Haemostasis
  The prothrombin time is therefore the time required for the plasma to clot after an excess of thromboplastin and an optimal concentration of calcium.
In this exercise, two tests will be performed to screen for defective clotting factors. The formation of thrombin in the plasma samples will be inhibited.
Tests to Measure Fibrin formation Mr. Mohammed A. Jaber.
Practical Hematology Lab
Investigation of Haemostasis MS. c. program Lab-9.
Lesson starter Once a protein has denatured, it cannot return to its original shape. Explain why. Haemoglobin is a protein found in the blood. Name two.
Activated Partial Thromboplastin Time (aPTT)
Solutions used in medical laboratory. O Solution is a homogeneous mixture of two or more substances. O Solute is the dissolved substance, whereas solvent.
Laboratory Testing in Coagulation Coagulation Keri Brophy-Martinez.
Factor Assays Robert Gosselin MT (ASCP), CLS.
1. Normal haemostasis Haemostasis is the process whereby haemorrhage following vascular injury is arrested. It depends on closely linked interaction.
EXP.2 (Quantitative determination of Amylase activity) Introduction:- The purpose of this experiment is to study the enzyme amylase which is found in saliva.
Cross-matching as part of Pre transfusion compatibility
Solutions used in medical laboratory
One-Stage Quantitative
MLAB Coagulation Keri Brophy-Martinez
Scenario F/ 86 Autoimmune hypothyroidism since 2001
Elvira Maličev Blood Transfusion Centre of Slovenia
General Approach in Investigation of Hemostasis
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States.
Quantitative tests for proteins
One Stage Factor V Assay
General Approach of Haemostasis
D- Xylose Absorption Test
Workflow Benefits of Test-specific thresholds on Sysmex CS analysers
General Approach in Investigation of Hemostasis
Evaluation of APTT clot waveform analysis by IL ACL TOP® in patients with Haemophilia and comparison to clot waveform analysis with MDA® 180 P-TH-568 Aghighi.
Methods to Detect Red Cell Membrane Disorders
University of North Carolina-Chapel Hill Division of Hematology
Mixing Studies-aPTT or PT 1:1 Mix
Coombs test practical(3)
Quantitative tests for proteins
Non Imaging In Vivo Red Cell Survival.
Activated Partial Thromboplastin Time (aPTT)
Kinetics analysis of β-fructofuranosidase enzyme
Quantitative tests for proteins
General Approach in Investigation of Hemostasis
Coagulation Factor Assays
Tests to measure fibrin clot
Practical Hematology Lab Osmotic Fragility Test
QUANTITATION OF METHEMOGLOBIN
Screening Tests Selection of reagents & Mixing studies
Practical Blood Bank Lab 1 ABO Grouping.
Quantitative tests for proteins
Quantitative tests for proteins
Principles of Coagulation Screening II
Human antibodies with specificity for the C2 domain of factor VIII are derived from VH1 germline genes by Edward N. van den Brink, Ellen A. M. Turenhout,
Practical Hematology Lab Osmotic Fragility Test
Tests to measure fibrin clot
Hexagonal Phospholipid Neutralization assay (STACLOT-LA).
Dr. Festus Njuguna Moi University/MTRH
Practical Hematology Lab Osmotic Fragility Test
Tests to measure fibrin clot
Practical Blood Bank Lab 11 Cyroglobulin.
Andreas Mayer, William Wickner, Albert Haas  Cell 
Presentation transcript:

HAEMOPHILIA TREATMENT CENTRE LAB FACILITIES DR. MEENA BEEBI PATHOLOGIST HEMOPHILIA TREATMENT CENTRE, D.H. ALUVA

Government Hospital, Aluva

FACTOR ASSAY PRINCIPLE Based on a comparison of the ability of dilutions of standard and test plasma to correct the APTT of a plasma known to be totally deficient in FVIII but containing all other factors

REAGENTS Standard plasma(PNP) Factor VIII Def. plasma APTT reagent and Cacl2 Imidazole Buffer Patient plasma

PLASTIC TUBES 1/10 1/20 1/40 500 500 900 900µI 500µl 500µl 100µl 500µl 500µl

GLASS TUBES 1/10 1/20 1/40 100µL of dilution +100µL of FVIII plasma Do APTT

Straight lines, parallel to other ,should be obtained Non parallel lines: Converging type-technical error inhibitor F.VIII <1% Diverging type- activated sample

Read off the conc of the test sample from the graph. The conc Read off the conc of the test sample from the graph.The conc.of the factor in standard plasma is already known. So Factor level in test sample/factor level in standard sample x100 gives you the actual factor level in patient Eg : 7/85 x100=6 IU/dl

Fully automated coagulometer STAGO –DESTINY PLUS

Refrigerated centrifuge Water Bath

Factor Levels Factor Level <1IU/dl _severe Hemophilia Factor Level 1_5IU/dl _Moderate Hemophilia Factor Level 5_50IU/dl_Mild Hemophilia

Factor Assay in Cryoprecipitate Cryoprecipitate usually show a Factor VIII level in the range 200-1000IU/dl In this case, a predilution of the sample to1in5 or1in 10 will reduce the conc., to a level such that the factor assay is possible.The prediluted sample is further diluted 1/10,1/20,1/40 in assay buffer and the assay done

Predilution can be done with either Assay buffer or Factor VIII Def Plasma(preffered)

Inhibitor Screening Inhibitors are Neutralizing Antibodies in patients who have been transfused with exogenous replacement factors Incidence of inhibitors in hemophilia A-20-35% Hemophilia B-1-6%

IN INHIBITORS Inhibitors are IgG antibodies reacting with the active sites of FVIII molecule primarily with the epitopes in the A2,A3,C1 and C2 domains Factor VIII combines with its inhibitors in a time dependant fashion If the patient´s inhibitor level is low,a higher dose of FVIII may be able to neutralize the inhibitors and allow haemostasis.Higher inhibitor levels require the use of bypassing agents

An inhibitor is suspected when it is difficult to control bleeding with the usual dose of clotting factor concentrate in a patient or if there are increased incidence of bleeding Affected by age,duration of treatment,genetic factors,concentrate type,environmental etc.

l Laboratory Diagnosis Screening Principle: APTT is determined on 50:50 incubated mix at 37º C as well as freshly prepared mix, after incubating at 37ºC.The degree of correction of each mix is compared Reagents PNP Test Plasma Reagents for APTT

Plastic Tubes A B C 0.5 ml plasma 0.5ml test plasma 50:50 MIX

Incubate for 2 hours at 37 deg Make a50:50 mix from tubes A and B at the end of second hour and mark it as D Perform an APTT in duplicate on A,B,Dand C(in that order)

SAMPLES 1 2 3 TEST PLASMA 90 FRESH MIX 45 48 70 INCUBATED MIX Normal Plasma APTT 35 Sec.

A difference of more than 5 seconds is considered positive. Classical Bethesda assay Modified Nijmigen Assay

Mixing studies showing presence of an inhibitor Incubation Mixture APTT at the start of incubation (in seconds) APTT after 2 hours(in seconds) Normal plasma 32 40 Factor VIII Def. plasma 90 95 50:50 Mix of Normal plasma and Def plasma No Inhibitor 37 45 1BU 53 5BU 43 64 20BU 54 92

Fi Fibrinogen Assay PRINCIPLE(Modified Clauss Assay) Dilutions of standard normal plasma with known Fibrinogen content are prepared and clotting time measured REAGENTS Reference Plasma Thrombin Solution of conc.30IU/ml- 100IU/ml Imidazole Buffer

METHOD Prepare 1/5,1/10.1/15,1/20 dilutions of reference plasma in Imidazole buffer Do Thrombin time at37ºC Plot on a log log graph paper with time in sec on X axis and fibrinogen conc. On Y axis.1/10 dilution represents the standard value(1.5g/l-3.5g/l) Dilute the test plasma (usually1/10 dilution) and do TT .Plot on the graph paper and find the value in seconds

Contd…. If you expect low value of fibrinogen then dilution of 1/5 or1/2 are taken accordingly and the conc obtained from the graph is multiplied by 5/10 and 2/10 respectively

THANK YOU